Journal List > J Rheum Dis > v.23(2) > 1064248

Cho, Kim, Choi, Lee, Bae, Kim, Yoo, and Sung: Impact of Patient Education on the Satisfaction of Rheumatoid Arthritis Patients: A Randomized Trial of Nurse-led Versus Medical Docter-led Education

Abstract

Objective

To examine the impact of patient education (PE) on patients' satisfaction in rheumatoid arthritis (RA) and to compare nurse-led education with medical doctor (MD)-led education.

Methods

Patients were enrolled by categorizing in two groups, nurse-led and MD-led education, randomization was performed. Face-to-face education was conducted two times, and changes in patient satisfaction before and after PE were assessed using the visual analogue scale (VAS; 0 to100 mm) and patients' satisfaction questionnaire (PSQ). Changes in patients' reported outcomes (PRO) were measured using disease activity score with 28 joint-erythrocyte sedimentation rate (DAS28-ESR), health assessment questionnaire (HAQ), and European quality of life-5 dimension (EQ-5D). Changes in patients' satisfaction and PRO between before and after PE were compared using paired t-test, and the comparison between nurse-led and MD-led education was analyzed using independent t-test.

Results

A total of 120 patients, 60 patients from each group, were randomized to receive either nurse-led or MD-led education. Among them, 113 patients completely received education and final assessment. In total patients, patients' satisfaction was significantly increased from 87.8±13.1 mm to 92.3±8.8 mm in VAS (p<0.01), and from 3.7±0.4 to 4.0±0.4 in PSQ (p<0.01). There was no improvement in DAS28-ESR, HAQ, but there was mild improvement in quality of life (QOL) after PE. Improvement of patients' satisfaction by PSQ after nurse-led education was 0.4±0.4 and it was higher than 0.3±0.5 after MD-led education, but it was not statistically different (p=0.25).

Conclusion

PE for RA patients improved patients' satisfaction and QOL. Nurse-led education showed comparable improvement in patients' satisfaction with MD-led education.

REFERENCES

1. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010; 376:1094–108.
crossref
2. Smolen JS, Landewé R, Breedveld FC, Buch M, Burmester G, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. 2014; 73:492–509.
3. Zangi HA, Ndosi M, Adams J, Andersen L, Bode C, Boström C, et al. EULAR recommendations for patient education for people with inflammatory arthritis. Ann Rheum Dis. 2015; 74:954–62.
crossref
4. Tiippana-Kinnunen T, Kautiainen H, Paimela L, Leirisalo-Repo M. Comorbidities in Finnish patients with rheumatoid arthritis: 15-year follow-up. Scand J Rheumatol. 2013; 42:451–6.
crossref
5. Albano MG, Giraudet-Le Quintrec JS, Crozet C, d'Ivernois JF. Characteristics and development of therapeutic patient education in rheumatoid arthritis: analysis of the 2003-2008 literature. Joint Bone Spine. 2010; 77:405–10.
crossref
6. van Eijk-Hustings Y, Ammerlaan J, Voorneveld-Nieuwen-huis H, Maat B, Veldhuizen C, Repping-Wuts H. Patients' needs and expectations with regard to rheumatology nursing care: results of multicentre focus group interviews. Ann Rheum Dis. 2013; 72:831–5.
crossref
7. Fall E, Chakroun N, Dalle N, Izaute M. Is patient education helpful in providing care for patients with rheumatoid arthritis? A qualitative study involving French nurses. Nurs Health Sci. 2013; 15:346–52.
crossref
8. Larsson I, Bergman S, Fridlund B, Arvidsson B. Patients' experiences of a nurse-led rheumatology clinic in Sweden: a qualitative study. Nurs Health Sci. 2012; 14:501–7.
crossref
9. Chew LC, Lim TG, Loy KL, Kong MC, Chang WT, Tan SB, et al. A questionnaire survey of patient experience with the Rheumatology Monitoring Clinic in Singapore. Int J Rheum Dis. 2012; 15:390–8.
crossref
10. Abourazzak F, El Mansouri L, Huchet D, Lozac'hmeur R, Hajjaj-Hassouni N, Ingels A, et al. Long-term effects of therapeutic education for patients with rheumatoid arthritis. Joint Bone Spine. 2009; 76:648–53.
crossref
11. Hammond A, Freeman K. One-year outcomes of a randomized controlled trial of an educational-behavioural joint protection programme for people with rheumatoid arthritis. Rheumatology (Oxford). 2001; 40:1044–51.
crossref
12. Hammond A, Freeman K. The long-term outcomes from a randomized controlled trial of an educational-behavioural joint protection programme for people with rheumatoid arthritis. Clin Rehabil. 2004; 18:520–8.
crossref
13. Masiero S, Boniolo A, Wassermann L, Machiedo H, Volante D, Punzi L. Effects of an educational-behavioral joint protection program on people with moderate to severe rheumatoid arthritis: a randomized controlled trial. Clin Rheumatol. 2007; 26:2043–50.
crossref
14. Im NY, Lee EY. Effects of short term selp-help education on pain, depression, self-efficacy, and quality of life in patients having chronic arthritis. J Rheum Health. 1997; 4:249–61.
15. Park IH. Effects of empowerment education program for the patients having rheumatoid arthritis on empowerment, health status and self-care activities [thesis]. Seoul: Chung-Ang University;. 2001.
16. Korean College of Rheumatology. Textbook of rheumatology. Seoul: Koon Ja;2014. p. 111–71.
17. de Wit MP, Smolen JS, Gossec L, van der Heijde DM. Treating rheumatoid arthritis to target: the patient version of the international recommendations. Ann Rheum Dis. 2011; 70:891–5.
crossref
18. van Eijk-Hustings Y, van Tubergen A, Boström C, Braychenko E, Buss B, Felix J, et al. EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis. Ann Rheum Dis. 2012; 71:13–9.
crossref
19. Ndosi M, Lewis M, Hale C, Quinn H, Ryan S, Emery P, et al. A randomised, controlled study of outcome and cost effectiveness for RA patients attending nurse-led rheumatology clinics: study protocol of an ongoing nationwide multicentre study. Int J Nurs Stud. 2011; 48:995–1001.
crossref
20. Primdahl J, Sørensen J, Horn HC, Petersen R, Hørslev-Petersen K. Shared care or nursing consultations as an alternative to rheumatologist follow-up for rheumatoid arthritis outpatients with low disease activity− patient outcomes from a 2-year, randomised controlled trial. Ann Rheum Dis. 2014; 73:357–64.
21. Koksvik HS, Hagen KB, Rødevand E, Mowinckel P, Kvien TK, Zangi HA. Patient satisfaction with nursing consultations in a rheumatology outpatient clinic: a 21-month randomised controlled trial in patients with inflammatory arthritides. Ann Rheum Dis. 2013; 72:836–43.
crossref
22. Hill J, Bird HA, Hopkins R, Lawton C, Wright V. Survey of satisfaction with care in a rheumatology outpatient clinic. Ann Rheum Dis. 1992; 51:195–7.
crossref
23. Unk JA, Brasington R. Efficacy study of multimedia rheumatoid arthritis patient education program. J Am Assoc Nurse Pract. 2014; 26:370–7.
crossref
24. Ndosi M, Johnson D, Young T, Hardware B, Hill J, Hale C, et al. Effects of needs-based patient education on self-efficacy and health outcomes in people with rheumatoid arthritis: a multicentre, single blind, randomised controlled trial. Ann Rheum Dis. 2015 Jul 10; [Epub].DOI: DOI: 10.1136/annrheum-dis-2014-207171.
crossref

Figure 1.
The flow of patient selection, randomization and follow-up. MD: medical doctor, RA: rheumatoid arthritis.
jrd-23-109f1.tif
Figure 2.
The change of patients' satisfaction and disease outcomes before and after education. (A) Change in patients' satisfaction with VAS before and after education. (B) Change in patients' satisfaction with PSQ before and after education. PSQ: patients' satisfaction questionnaire, VAS: visual analogue scale.
jrd-23-109f2.tif
Table 1.
Baseline characteristics of rheumatoid arthritis patients
Feature Total (n=120) Nurse-led education (n=60) MD-led education (n=60) p-value
Age (yr) 48.0 (37.3∼55.8) 48.5 (39.3∼56.0) 48.0 (36.3∼55.0) 0.30
Female 113 (94.2) 56 (93.3) 57 (95.0) 0.70
Duration of education (yr) 13.0 (12.0∼16.0) 12.0 (12.0∼16.0) 14.0 (12.0∼16.0) 0.53
BMI (kg/m2) 22.8±3.6 23.2±3.7 22.4±3.6 0.21
Disease duration (mo) 58.0 (10.0∼92.0) 63.0 (9.5∼123.8) 52.5 (10.0∼80.0) 0.31
DAS28-ESR 3.8±1.3 3.9±1.3 3.8±1.3 0.62
DAS28-CRP 2.8±1.1 2.9±1.1 2.7±1.2 0.51
Physician VAS (mm) 10.0 (10.0∼30.0) 10.0 (10.0∼20.0) 20.0 (10.0∼30.0) 0.37
RF positivity 104 (86.7) 51 (85.0) 53 (88.3) 0.59
Anti-CCP positivity 106 (88.3) 53 (88.3) 53 (88.3) 0.58
MTX use 111 (92.5) 52 (86.7) 59 (98.3) 0.02
MTX dosage (mg/wk) 12.5 (10.0∼15.0) 12.5 (10.0∼15.0) 12.5 (10.0∼15.0) 0.52
Corticosteroid use 89 (74.2) 43 (71.7) 46 (76.7) 0.53
Corticosteroid dosage (mg/d) 2.5 (0.6∼5.0) 2.5 (1.3∼ 2.5) 2.5 (0.0∼5.0) 0.43
Biologic DMARDs use 40 (33.3) 20 (33.3) 20 (33.3) 1.00
HAQ-DI 0.5 (0.0∼1.0) 0.4 (0.0∼0.9) 0.5 (0.2∼1.0) 0.16

Values are presented as median (range), number (%), or mean±standard deviation. BMI: body mass index, CCP: cyclic citrullinated peptides, CRP: C-reactive protein, DAS28: disease activity score with 28 joint, DMARDs: disease modifying antirheumatic drugs, ESR: erythrocyte sedimentation rate, HAQ-DI: health assessment questionnaire disability index, MD: medical doctor, MTX: methotrexate, RF: rheumatoid factor, VAS: visual analogue scale.

Table 2.
Comparison of the change of patients' satisfaction between nurse-led education and MD-led education
PSQ Total Nurse-led education (n=60) MD-led education (n=60) p-value
General satisfaction        
 Before education 3.2±0.4 3.2±0.5 3.2±0.3 0.76
 After education 3.4±0.4 3.3±0.4 3.4±0.3 0.26
 Change between pre and post-education 0.2±0.4* 0.1±0.5 0.2±0.3 0.32
Giving of information        
 Before education 3.7±0.5 3.7±0.6 3.7±0.4 0.85
 After education 4.2±0.4 4.2±0.4 4.1±0.4 0.38
 Change between pre and post-education 0.4±0.5* 0.5±0.5 0.4±0.5 0.28
Empathy with the patient        
 Before education 3.8±0.5 3.8±0.6 3.8±0.5 0.36
 After education 4.1±0.6 4.1±0.6 4.1±0.5 0.86
 Change between pre and post-education 0.3±0.7* 0.3±0.7 0.3±0.7 0.57
Technical quality and competence        
 Before education 4.2±0.5 4.2±0.6 4.2±0.4 0.80
 After education 4.4±0.5 4.5±0.6 4.4±0.5 0.35
 Change between pre and post-education 0.2±0.7* 0.3±0.7 0.2±0.6 0.33
Attitude towards the patient        
 Before education 3.7±0.6 3.7±0.7 3.8±0.5 0.76
 After education 3.9±0.6 4.0±0.7 3.9±0.6 0.30
 Change between pre and post-education 0.2±0.6* 0.3±0.7 0.1±0.6 0.20
Access and continuity        
 Before education 3.6±0.5 3.6±0.6 3.6±0.5 0.74
 After education 3.8±0.7 3.8±0.7 3.7±0.6 0.55
 Change between pre and post-education 0.2±0.7* 0.2±0.6 0.2±0.7 0.75
Overall satisfaction        
 Before education 3.7±0.4 3.7±0.5 3.7±0.4 0.81
 After education 4.0±0.4* 4.0±0.4 4.0±0.4 0.43
 Change between pre and post-education 0.3±0.4 0.3±0.4 0.2±0.4 0.26

Values are presented as mean±standard deviation. Pateints' satisfaction was measured with the patients' satisfaction questionnaire (PSQ). MD: medical doctor.

* p<0.01, paired t-test between PSQ before education and PSQ after education.

Table 3.
The change of patient satisfaction according to patients' characteristics
Patients' satisfaction Group I (n=40) Group II (n=40) Group III (n=40) p-value
VAS (mm)        
 Before education 85.5±15.7 91.0±10.8 87.0±12.0 0.15
 After education 93.7±7.5 92.2±9.3 91.0±8.8 0.42
 Improvement 8.9±12.9 1.9±10.6 4.1±9.7 0.02
PSQ        
 Before education 3.6±0.4 3.8±0.4 3.7±0.4 0.11
 After education 4.1±0.4 4.0±0.4 3.9±0.4 0.30
 Improvement 0.5±0.5 0.2±0.3 0.2±0.4 0.01

Values are presented as mean±standard deviation. Patients group were classified according to disease duration and antirheumatic drugs. Group I: patients who were less than 2 years after RA diagnosis, Group II: patients who were more than 2 years after RA diagnosis, Group III: patients treated with biologic disease modifying antirheumatic drugs. PSQ: patients' satisfaction questionnaire, RA: rheumatoid arthritis, VAS: visual analogue scale.

Table 4.
Impact of patient education on patient reported outcomes according to educator
Feature Total (n=120) p-value Nurse-led group (n=60) MD-led group (n=60) p-value
DAS28-ESR          
 Before education 3.8±1.3   3.9±1.3 3.8±1.3 0.62
 After education 3.6±1.2   3.6±1.1 3.7±1.3 0.51
 Improvement 0.2±1.1 0.20* 0.3±1.1 −0.002±1.1 0.13
HAQ-DI          
 Before education 0.6±0.6   0.7±0.6 0.5±0.5 0.16
 After education 0.7±0.6   0.7±0.6 0.6±0.6 0.17
 Improvement −0.07±0.44 0.07* −0.05±0.53 −0.10±0.35 0.63
EQ-5D          
 Before education 0.8±0.1   0.8±0.1 0.8±0.1 0.56
 After education 0.8±0.1   0.8±0.1 0.8±0.1 1.00
 Improvement 0.02±0.12 0.01* 0.04±0.11 0.01±0.14 0.19

Values are presented as mean±standard deviation. DAS28: disease activity score with 28 joint, EQ-5D: European quality of life-5 dimension, ESR: erythrocyte sedimentation rate, HAQ-DI: health assessment questionnaire disability index, MD: medical doctor.

* Paired t-test.

Table 5.
Impact of patient education on patient reported outcomes according to patients' characteristics
Feature Group I (n=40) Group II (n=40) Group III (n=40) p-value
DAS28-ESR        
 Before education 3.5±1.4 3.6±1.1 4.4±1.3 0.002
 After education 3.3±1.2 3.6±1.1 4.1±1.0 0.007
 Improvement 0.2±1.1 −0.03±1.1 0.26±1.1 0.60
HAQ-DI        
 Before education 0.46±0.55 0.45±0.46 0.91±0.62 <0.01
 After education 0.48±0.51 0.47±0.57 0.98±0.59 <0.01
 Improvement −0.03±0.52 −0.11±0.35 −0.11±0.41 0.69
EQ-5D        
 Before education 0.78±0.10 0.80±0.09 0.72±0.12 0.001
 After education 0.80±0.11 0.82±0.13 0.77±0.12 0.19
 Improvement 0.02±0.13 −0.0002±0.13 0.05±0.12 0.33

Values are presented as mean±standard deviation. Group I: patients who were less than 2 years after RA diagnosis, Group II: patients who were more than 2 years after RA diagnosis, Group III: patients treated with biologic disease modifying antirheumatic drugs. MD: medical doctor, DAS28: disease activity score with 28 joint, ESR: erythrocyte sedimentation rate, HAQ-DI: health assessment questionnaire disability index, EQ-5D: European quality of life-5 dimension, RA: rheumatoid arthritis.

TOOLS
Similar articles